Literature DB >> 17880003

8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease.

Leila Choe1, Mark D'Ascenzo, Norman R Relkin, Darryl Pappin, Philip Ross, Brian Williamson, Steven Guertin, Patrick Pribil, Kelvin H Lee.   

Abstract

An 8-plex version of an isobaric reagent for the quantitation of proteins using shotgun methods is presented. The 8-plex version of the reagent relies on amine-labeling chemistry of peptides similar to 4-plex reagents. MS/MS reporter ions at 113, 114, 115, 116, 117, 118, 119, and 121 m/z are used to quantify protein expression. This technology which was first applied to a test mixture consisting of eight proteins and resulted in accurate quantitation, has the potential to increase throughput of analysis for quantitative shotgun proteomics experiments when compared to 2- and 4-plex methods. The technology was subsequently applied to a longitudinal study of cerebrospinal fluid (CSF) proteins from subjects undergoing intravenous Ig treatment for Alzheimer's disease. Results from this study identify a number of protein expression changes that occur in CSF after 3 and 6 months of treatment compared to a baseline and compared to a drug washout period. A visualization tool was developed for this dataset and is presented. The tool can aid in the identification of key peptides and measurements. One conclusion aided by the visualization tool is that there are differences in considering peptide-based observations versus protein-based observations from quantitative shotgun proteomics studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880003      PMCID: PMC3594777          DOI: 10.1002/pmic.200700316

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  17 in total

Review 1.  Proteomics: a technology-driven and technology-limited discovery science.

Authors:  K H Lee
Journal:  Trends Biotechnol       Date:  2001-06       Impact factor: 19.536

Review 2.  Shotgun proteomics: integrating technologies to answer biological questions.

Authors:  W Hayes McDonald; John R Yates
Journal:  Curr Opin Mol Ther       Date:  2003-06

3.  Quantitative and qualitative measure of intralaboratory two-dimensional protein gel reproducibility and the effects of sample preparation, sample load, and image analysis.

Authors:  Leila H Choe; Kelvin H Lee
Journal:  Electrophoresis       Date:  2003-10       Impact factor: 3.535

4.  Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease.

Authors:  R C Dodel; Y Du; C Depboylu; H Hampel; L Frölich; A Haag; U Hemmeter; S Paulsen; S J Teipel; S Brettschneider; A Spottke; C Nölker; H J Möller; X Wei; M Farlow; N Sommer; W H Oertel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-10       Impact factor: 10.154

5.  Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseases.

Authors:  U Eder; B Leitner; R Kirchmair; P Pohl; K A Jobst; A D Smith; J Málly; A Benzer; P Riederer; H Reichmann; A Saria; H Winkler
Journal:  J Neural Transm (Vienna)       Date:  1998       Impact factor: 3.575

6.  Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.

Authors:  D Schenk; R Barbour; W Dunn; G Gordon; H Grajeda; T Guido; K Hu; J Huang; K Johnson-Wood; K Khan; D Kholodenko; M Lee; Z Liao; I Lieberburg; R Motter; L Mutter; F Soriano; G Shopp; N Vasquez; C Vandevert; S Walker; M Wogulis; T Yednock; D Games; P Seubert
Journal:  Nature       Date:  1999-07-08       Impact factor: 49.962

7.  Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease.

Authors:  Erin J Finehout; Zsofia Franck; Leila H Choe; Norman Relkin; Kelvin H Lee
Journal:  Ann Neurol       Date:  2007-02       Impact factor: 10.422

8.  Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease.

Authors:  Maja Puchades; Sara Folkesson Hansson; Carol L Nilsson; Niels Andreasen; Kaj Blennow; Pia Davidsson
Journal:  Brain Res Mol Brain Res       Date:  2003-10-21

9.  Alpha-2 macroglobulin is genetically associated with Alzheimer disease.

Authors:  D Blacker; M A Wilcox; N M Laird; L Rodes; S M Horvath; R C Go; R Perry; B Watson; S S Bassett; M G McInnis; M S Albert; B T Hyman; R E Tanzi
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

10.  Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals.

Authors:  Marc E Weksler; Norman Relkin; Rimma Turkenich; Susan LaRusse; Ling Zhou; Paul Szabo
Journal:  Exp Gerontol       Date:  2002-07       Impact factor: 4.032

View more
  100 in total

1.  Addressing accuracy and precision issues in iTRAQ quantitation.

Authors:  Natasha A Karp; Wolfgang Huber; Pawel G Sadowski; Philip D Charles; Svenja V Hester; Kathryn S Lilley
Journal:  Mol Cell Proteomics       Date:  2010-04-10       Impact factor: 5.911

2.  Relative, label-free protein quantitation: spectral counting error statistics from nine replicate MudPIT samples.

Authors:  Bret Cooper; Jian Feng; Wesley M Garrett
Journal:  J Am Soc Mass Spectrom       Date:  2010-05-06       Impact factor: 3.109

3.  A proteomic approach for plasma biomarker discovery with 8-plex iTRAQ labeling and SCX-LC-MS/MS.

Authors:  Haige Ye; Li Sun; Xiaojun Huang; Ping Zhang; Xiaoshu Zhao
Journal:  Mol Cell Biochem       Date:  2010-06-05       Impact factor: 3.396

Review 4.  Systems biology in immunology: a computational modeling perspective.

Authors:  Ronald N Germain; Martin Meier-Schellersheim; Aleksandra Nita-Lazar; Iain D C Fraser
Journal:  Annu Rev Immunol       Date:  2011       Impact factor: 28.527

5.  Quantification of tryptic peptides in quadrupole ion trap using high-mass signals derived from isotope-coded N-acetyl dipeptide tags.

Authors:  Jongcheol Seo; Hye-Joo Yoon; Seung Koo Shin
Journal:  J Am Soc Mass Spectrom       Date:  2011-07-06       Impact factor: 3.109

Review 6.  A Biologist's Field Guide to Multiplexed Quantitative Proteomics.

Authors:  Corey E Bakalarski; Donald S Kirkpatrick
Journal:  Mol Cell Proteomics       Date:  2016-02-12       Impact factor: 5.911

7.  Temporal analysis of neural differentiation using quantitative proteomics.

Authors:  Raghothama Chaerkady; Candace L Kerr; Arivusudar Marimuthu; Dhanashree S Kelkar; Manoj Kumar Kashyap; Marjan Gucek; John D Gearhart; Akhilesh Pandey
Journal:  J Proteome Res       Date:  2009-03       Impact factor: 4.466

8.  Time-resolved analysis of the matrix metalloproteinase 10 substrate degradome.

Authors:  Pascal Schlage; Fabian E Egli; Paolo Nanni; Lauren W Wang; Jayachandran N Kizhakkedathu; Suneel S Apte; Ulrich auf dem Keller
Journal:  Mol Cell Proteomics       Date:  2013-11-26       Impact factor: 5.911

Review 9.  Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics.

Authors:  Yahui Liu; Hong Qing; Yulin Deng
Journal:  Int J Mol Sci       Date:  2014-05-06       Impact factor: 5.923

10.  Shotgun proteomics in neuroscience.

Authors:  Lujian Liao; Daniel B McClatchy; John R Yates
Journal:  Neuron       Date:  2009-07-16       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.